AcousticaBio

Biotechnology ResearchMassachusetts, United States11-50 Employees

AcousticaBio enables biologic drugs to move from infusion to injection. 

We help biopharmaceutical companies formulate new and existing biologics into ultra-high-concentration, small-volume subcutaneous injections, overcoming the viscosity, stability, and manufacturability challenges that typically limit injectable delivery. 

Powered by our proprietary, Harvard-patented acoustophoretic technology, we transform therapies traditionally administered through lengthy IV infusions into patient-friendly injections, without solvents or complex post-processing. The result: biologics that are easier to deliver, easier to manufacture, and better aligned with patient needs. 

Our platform supports a broad range of modalities, helping developers expand delivery options, improve patient experience, unlock new value across their pipelines, and set the stage for commercially viable drugs.

Sign up for free to view info

Email Format Employee directory